{"nct_id":"NCT04629703","title":"Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects","status":"COMPLETED","status_verified_date":"2023-08","start_date":"2021-03-25","start_date_type":"ACTUAL","primary_completion_date":"2022-09-05","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["RIGL"]}